Brightsurf Science News and Current Science News Events
 

Liver Cancer News | Liver Cancer Current Events
Page 1 of 108 | 2693 Results
Previous0102030405060708091011   Next   
Sort By: Page Views | Date
Scientific evidence of the significant anti-cancer effect of milk thistle
Recently, scientists demonstrated the anti-cancer effects of silibinin, a major biologically active compound of milk thistle. Being widely used as a folk remedy for liver diseases, milk thistle is safe and well-tolerated, and it protects the liver from drug or alcohol-related injury.   view more (2007-11-15)

Doubling of deaths from liver cancer in 30 years
Deaths from liver cancer have almost doubled in the past 30 years, shows research in Gut. A relatively rare type of liver cancer arising from the bile ducts - intrahepatic cholangiocarcinoma - accounts for virtually all of the increase. The research team analysed deaths coded by liver tumour... view more (2001-05-16)

New study finds advanced liver cancer patients live longer by taking anti-cancer drug sorafenib
Researchers at Mount Sinai School of Medicine in New York have found that sorafenib (Nexavar) helps patients with advanced liver cancer live about 44 percent longer compared with patients who did not receive the anti-cancer drug.   view more (2008-07-24)

CHEMOEMBOLISATION OFFERS SURVIVAL BENEFIT FOR PEOPLE WITH LIVER CANCER (p 1734)
People with liver cancer that cannot be treated with surgical resection or transplantation could have an increased two-year survival if they are given chemoembolisation-a procedure in which blood supply to the tumour combined with the effect of chemotherapy inhibits cancer growth. There is no... view more (2002-05-15)

In 'Spontaneous' Liver Cancer, Researcher Sees a Cure
Adding more good news to last week's announcement that Nexavar® (sorafenib) may be the first effective treatment for advanced liver cancer, researchers at the Lombardi Comprehensive Cancer Center at Georgetown University have uncovered a new molecular mechanism that may... view more (2007-06-20)

Targeting nerve growth factor may cure liver cancer
Nerve growth factor (NGF), as the name says, is an essential peptide factor for the growth and differentiation of neuronal cells. Therefore we can imagine that this growth factor is important for the nervous system including brain.   view more (2007-09-19)

Losing a bit of weight and doing some exercise slows progression of chronic liver disease
Losing weight and exercising regularly slows progression of chronic liver disease in those who are overweight, indicates a study in Gut. Being overweight is bad for the liver. And non-alcoholic fatty liver is increasingly being diagnosed in those who are overweight, diabetic, or who have insulin... view more (2004-02-11)

Skin rash in patients treated for liver cancer determines survival
In a study of a new chemotherapy drug for liver cancer, researchers found that the development of a skin rash correlated directly with the patient's response to treatment.   view more (2006-06-05)

Correlation between bile duct obstruction and ductal cancer found
When bile duct cancer cells were placed in the liver of animals with bile duct obstruction, they grew more rapidly than identical cells placed in animals without bile duct obstruction.   view more (2007-04-30)

Researchers aim to cut future need for liver transplants
University of Edinburgh scientists have identified primitive liver cells —possibly dormant from the earliest developmental stage of a human being — which have the potential to mature into different cells types and help repair a failing liver.   view more (2006-07-07)

Cancer Research UK supports additional TroVax phase II trial in colorectal cancer
Oxford BioMedica announced today that Cancer Research UK (CRUK) has agreed to conduct and sponsor an open label Phase II trial with Oxford BioMedica's leading cancer immunotherapy product, TroVax®, in colorectal cancer patients who have liver metastases. The decision by CRUK follows extensive... view more (2003-08-28)

Cancer-fighting virus shows promise in early clinical trial
A virus that has been specifically designed by scientists to be safe to normal tissue but deadly to cancer is showing early promise in a preliminary study, researchers said today at the ESMO Conference Lugano (ECLU), Switzerland.   view more (2007-07-09)

New test improves detection of liver cancer
Cancer of the liver is very difficult to detect, and it is a major cause of death in Asia and Africa, with rising incidence in Western countries as well.   view more (2007-08-09)

Research offers hope of new treatments for liver damage 'plague'
Millions of patients suffering from liver damage (cirrhosis) and failure may benefit from research by the Universities of Southampton and Edinburgh that could lead to new life-saving treatments. There is currently no cure for liver cirrhosis and a patient's only hope of survival is to receive a... view more (2005-01-05)

New test detects cirrhosis of the liver in an early stage
Ghent researchers have developed a new and easy method of detecting cirrhosis of the liver. This major finding helps predict the evolution of chronic liver disease, allowing physicians to start proper treatment early on. Patients suffering from this serious, progressive disease in its cirrhosis... view more (2004-03-08)

New technique in treating patients with liver cancer proves effective
Use of multipolar radiofrequency ablation in the treatment of colorectal liver metastases is effective and has a relatively low recurrence rate, according to a recent study conducted by researchers at Charité, Campus Benjamin Franklin in Berlin, Germany.   view more (2008-04-14)

Penn researchers find targeted therapy combination overcomes treatment resistance in liver cancer
Researchers at the University of Pennsylvania School of Medicine and Abramson Cancer Center reported today at the annual meeting of the American Association for Cancer Research that combining two targeted therapies overcomes treatment resistance in liver cancer cell lines. The team is currently... view more (2008-04-14)

Should living liver donation be available in the NHS?
Living liver donation should be available on the NHS, although it should not be adopted without full public debate and agreement because of the risks to donors, argue researchers in this week's BMJ. Living liver donation could benefit patients who are likely to die or deteriorate before a cadaveric... view more (2003-09-17)

1 surgery better than 2 for some colorectal cancer patients
A single surgery to remove cancer from both the colon and the liver to which it has spread may be better in some cases than the current standard treatment of two separate surgeries with chemotherapy in between, according to a study led by Duke University Medical Center researchers.   view more (2007-03-19)

Cycles of cell death, proliferation key to liver cancer
Research at the University of California, San Diego (UCSD) School of Medicine shows that liver cancer is likely caused by cycles of liver cell death and renewal.   view more (2006-06-23)

Nexavar shown to significantly extend survival for patients with advanced liver cancer
Bayer Pharmaceuticals Corporation (NYSE: BAY) and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that an independent data monitoring committee (DMC) has reviewed the safety and efficacy data from the companies' pivotal Phase 3 trial in patients with advanced hepatocellular carcinoma... view more (2007-02-13)

Women given liver transplants outlive male recipients by around 4 years
Female liver transplant recipients outlive men given the same procedure by an average of 4.5 years, suggests research published ahead of print in Gut.   view more (2006-09-28)

Antibody retards growth and induces death in liver cancer cells
Researchers from the University of Pittsburgh School of Medicine report a significant new advance in the search for an effective treatment for human liver cancer in the July issue of Molecular Cancer Therapeutics.   view more (2007-07-12)

New Jefferson Trial to Test Radiation-Emitting Beads Against Advanced Liver Cancer
Liver cancer specialists at Jefferson's Kimmel Cancer Center in Philadelphia are beginning an 18-month study of a new treatment for liver cancer. The therapy entails injecting tiny beads that emit small amounts of radiation into the liver's main artery while also blocking the blood supply feeding... view more (2008-02-13)

New therapy shows promise for fighting treatment-resistant cancer cells
A gene radiotherapy system that detects and treats cancer cells that are resistant to traditional forms of chemotherapy and radiation showed success in the laboratory and could eventually prove beneficial for cancer patients, according to researchers at SNM's 55th Annual Meeting.   view more (2008-06-17)
Page 1 of 108 | 2693 Results
Previous0102030405060708091011   Next   
Sort By: Page Views | Date
© 2008 BrightSurf.com